Pro Share Advisors LLC Precigen, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 40,922 shares of PGEN stock, worth $34,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,922

Previous 33,215 23.2%

Holding current value

$34,374

Previous $52,000 26.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.91 - $1.88 $7,013 - $14,489	7,707 Added 23.2%	40,922 $38,000
Q2 2024 Aug 13, 2024	SELL	$1.27 - $1.75 $10,008 - $13,791	-7,881 Reduced 19.18%	33,215 $52,000
Q1 2024 May 08, 2024	BUY	$1.21 - $1.75 $3,420 - $4,947	2,827 Added 7.39%	41,096 $59,000
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $3,572 - $5,659	4,014 Added 11.72%	38,269 $51,000
Q3 2023 Nov 13, 2023	BUY	$1.08 - $1.85 $163 - $279	151 Added 0.44%	34,255 $48,000
Q2 2023 Aug 10, 2023	BUY	$0.96 - $1.4 $2,250 - $3,281	2,344 Added 7.38%	34,104 $39,000
Q1 2023 May 11, 2023	BUY	$0.88 - $2.19 $1,370 - $3,409	1,557 Added 5.16%	31,760 $33,000
Q4 2022 Feb 02, 2023	BUY	$1.27 - $2.26 $1,988 - $3,539	1,566 Added 5.47%	30,203 $45,000
Q3 2022 Nov 04, 2022	BUY	$1.41 - $2.79 $1,584 - $3,135	1,124 Added 4.09%	28,637 $61,000
Q2 2022 Aug 01, 2022	SELL	$1.15 - $2.53 $13,413 - $29,509	-11,664 Reduced 29.77%	27,513 $37,000
Q1 2022 May 10, 2022	SELL	$1.91 - $3.98 $20,291 - $42,283	-10,624 Reduced 21.33%	39,177 $83,000
Q4 2021 Feb 08, 2022	SELL	$3.53 - $5.5 $22,934 - $35,733	-6,497 Reduced 11.54%	49,801 $185,000
Q3 2021 Nov 12, 2021	SELL	$4.99 - $6.55 $26,836 - $35,225	-5,378 Reduced 8.72%	56,298 $281,000
Q2 2021 Aug 13, 2021	BUY	$6.24 - $8.22 $93,537 - $123,217	14,990 Added 32.11%	61,676 $402,000
Q1 2021 May 14, 2021	BUY	$6.74 - $10.95 $22,868 - $37,153	3,393 Added 7.84%	46,686 $322,000
Q4 2020 Feb 09, 2021	BUY	$3.75 - $10.56 $27,776 - $78,217	7,407 Added 20.64%	43,293 $442,000
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $1,729 - $3,062	-494 Reduced 1.36%	35,886 $126,000
Q2 2020 Aug 03, 2020	BUY	$2.16 - $5.46 $20,999 - $53,082	9,722 Added 36.47%	36,380 $182,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $38,920 - $191,671	26,658 New	26,658 $91,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Precigen, Inc. Transaction History